$CE

Kyrish Chuck purchased $105K of CE

Kyrish Chuck (SVP & CFO) purchased 2,300 shares of Celanese Corp (CE) at an average of $45.52 ($45.50–$45.53, $0.10M total) across 3 trades on 2026-08-14.

Original reporting
SEC EDGAR · Kyrish Chuck
Published Aug 17, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CE
Neutral
medium confidence
Mentioned
$CE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CENeutralLow
01

Why it matters

The only new information is the insider’s open-market purchase details (shares, price range, total value, and post-transaction holdings).

02

Market read

Traders may treat this as a mild sentiment input, but it does not provide a new fundamental driver for CE.

03

What to watch

The article does not state whether the purchase was part of a broader pattern, nor does it include any concurrent company-specific news that would validate the buy as a new catalyst.

Relevance 5/10Novelty 3/10Timing: Form 4 filed 2026-08-17, covering purchases dated 2026-08-14.

Background

The article is a SEC Form 4 insider transaction disclosure for Celanese (CE) by its SVP and CFO, Kyrish Chuck.

Company-level read

Ticker impact

$CENeutralMedium confidence
Context

Celanese CFO Kyrish Chuck bought $104,698 of CE shares in an open-market Form 4 filing on 2026-08-14, reported 2026-08-17.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely short-lived.

Evidence & confidence

This is a routine insider open-market purchase with no 10b5-1 plan and no accompanying company guidance, contract, or earnings datapoint in the text.

Market effects

No sector-wide implication is provided; the disclosure is company-specific and small in scale relative to typical sector flows.

None indicated.

None indicated.

Counterpoint

Insider purchases can be driven by diversification, liquidity needs, or routine compensation-related behavior, so the signal may be weak.

Key entities

  • Celanese Corp

    Subject of the Form 4 insider transaction disclosure.

  • Kyrish Chuck

    SVP and CFO who reported an open-market purchase of CE shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CEHighAI 8/10

Why is Celanese stock rallying today?

Celanese (CE) shares rose 7.5% after announcing immediate price hikes for key products in multiple regions, seen as a catalyst for margin recovery. The move is part of broader restructuring efforts, including asset sales. The company maintained its 2026 EPS guidance. The rally is company-specific, not driven by broader market trends. CE operates as a major producer of acetic acid and vinyl acetate monomer.

$CEMed

Celanese Stock Falls As Sudden Price Hike Spooks Market

Celanese (CE) shares fell after the company announced immediate price hikes on key acetyl products in multiple regions. Investors reacted to potential cost pressures and demand concerns, though no changes to price targets were announced. The company's long-term strategy includes cost cuts and debt reduction, but profitability challenges and high debt levels remain risks.

$CEMed

KeyBanc initiates Celanese stock coverage with overweight rating

KeyBanc initiated coverage on Celanese (NYSE: CE) with an overweight rating and a $57 price target, citing attractive valuation and strong free cash flow yield. The firm estimates the company has sufficient liquidity to repay debt through 2028. Celanese's Q2 2026 earnings beat estimates but revenue missed slightly, with a cautious outlook due to restructuring and leverage concerns.

$CEMed

Mitsui to Integrate Nutrinova's Upstream Materials Production and Make Nutrinova a Consolidated Subsidiary

Mitsui & Co. will integrate upstream operations at VP4, a German producer of key intermediates for Nutrinova's food ingredients. Mitsui will acquire an additional 19% stake in Nutrinova from Celanese, increasing its holding to 89% and making Nutrinova a consolidated subsidiary. This move aims to secure supply, improve cost competitiveness, and align with Mitsui's growth strategy in the Food Science business.